Package 59651-846-01

{"route": ["ORAL"], "spl_id": "b9ab1deb-dba4-4403-9121-936278cc4cfe", "openfda": {"upc": ["0359651847015"], "unii": ["ZG7E5POY8O"], "rxcui": ["993503", "993518", "993536"], "spl_set_id": ["8f86f677-2ebd-43c4-b2dd-2e07d4d54147"], "manufacturer_name": ["Aurobindo Pharma Limited"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (59651-846-01)", "package_ndc": "59651-846-01", "marketing_start_date": "20250603"}, {"sample": false, "description": "500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (59651-846-05)", "package_ndc": "59651-846-05", "marketing_start_date": "20250603"}], "brand_name": "BUPROPION HYDROCHLORIDE", "product_id": "59651-846_b9ab1deb-dba4-4403-9121-936278cc4cfe", "dosage_form": "TABLET, FILM COATED, EXTENDED RELEASE", "pharm_class": ["Aminoketone [EPC]", "Dopamine Uptake Inhibitors [MoA]", "Increased Dopamine Activity [PE]", "Increased Norepinephrine Activity [PE]", "Norepinephrine Uptake Inhibitors [MoA]"], "product_ndc": "59651-846", "generic_name": "BUPROPION HYDROCHLORIDE", "labeler_name": "Aurobindo Pharma Limited", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "BUPROPION HYDROCHLORIDE", "active_ingredients": [{"name": "BUPROPION HYDROCHLORIDE", "strength": "100 mg/1"}], "application_number": "ANDA090325", "marketing_category": "ANDA", "marketing_start_date": "20250603", "listing_expiration_date": "20261231"}